Bank of Montreal
HZNP

Bank of Montreal’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bank of Montreal’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-153,685
Closed -$17.7M – 4426
2023
Q3 		$17.7M Sell
153,685
-1,039,810
-87% -$112M 0.01% 757
2023
Q2 		$123M Buy
1,193,495
+370,098
+45% +$39M 0.04% 222
2023
Q1 		$90.3M Buy
823,397
+5,123
+0.6% +$566K 0.04% 257
2022
Q4 		$93.1M Sell
818,274
-41,528
-5% -$3.45M 0.04% 255
2022
Q3 		$55K Buy
859,802
+12,724
+2% +$889K 0.02% 342
2022
Q2 		$72.3K Sell
847,078
-118,175
-12% -$11.2M 0.03% 303
2022
Q1 		$102M Sell
965,253
-306,239
-24% -$29.8M 0.05% 266
2021
Q4 		$138M Sell
1,271,492
-30,051
-2% -$3.28M 0.07% 205
2021
Q3 		$145M Buy
1,301,543
+489,075
+60% +$50.8M 0.07% 250
2021
Q2 		$77.6M Buy
812,468
+711,018
+701% +$65.4M 0.04% 383
2021
Q1 		$9.23M Sell
101,450
-340,251
-77% -$28.7M 0.01% 1054
2020
Q4 		$34.8M Sell
441,701
-81,543
-16% -$6.06M 0.02% 520
2020
Q3 		$41.9M Sell
523,244
-99,815
-16% -$6.87M 0.04% 379
2020
Q2 		$36.1M Sell
623,059
-451,325
-42% -$19.3M 0.03% 411
2020
Q1 		$34.2M Sell
1,074,384
-15,240
-1% -$516K 0.04% 357
2019
Q4 		$39.4M Buy
1,089,624
+1,073,016
+6,461% +$32.9M 0.03% 472
2019
Q3 		$451K Buy
16,608
+12,777
+334% +$330K ﹤0.01% 2467
2019
Q2 		$92K Buy
3,831
+1,201
+46% +$30.5K ﹤0.01% 3389
2019
Q1 		$70K Sell
2,630
-2,253
-46% -$53.4K ﹤0.01% 3220
2018
Q4 		$95K Sell
4,883
-141,602
-97% -$2.78M ﹤0.01% 2974
2018
Q3 		$2.87M Sell
146,485
-22,265
-13% -$423K ﹤0.01% 1473
2018
Q2 		$2.79M Buy
168,750
+166,230
+6,596% +$2.53M ﹤0.01% 1464
2018
Q1 		$36K Hold
2,520
– – ﹤0.01% 3366
2017
Q4 		$37K Buy
2,520
+279
+12% +$3.92K ﹤0.01% 3386
2017
Q3 		$28K Sell
2,241
-7,568
-77% -$96.2K ﹤0.01% 3420
2017
Q2 		$116K Buy
9,809
+1,378
+16% +$17.1K ﹤0.01% 2924
2017
Q1 		$125K Sell
8,431
-123,082
-94% -$1.99M ﹤0.01% 2709
2016
Q4 		$2.6M Sell
131,513
-372,923
-74% -$6.76M ﹤0.01% 1402
2016
Q3 		$9.14M Sell
504,436
-114,425
-18% -$2.24M 0.01% 852
2016
Q2 		$10.2M Sell
618,861
-258,691
-29% -$4.19M 0.01% 790
2016
Q1 		$14.5M Buy
877,552
+4,966
+0.6% +$86.9K 0.02% 601
2015
Q4 		$18.9M Sell
872,586
-83,563
-9% -$1.63M 0.02% 501
2015
Q3 		$19M Buy
956,149
+174,639
+22% +$5.52M 0.03% 471
2015
Q2 		$27.1M Sell
781,510
-113,984
-13% -$3.48M 0.03% 421
2015
Q1 		$23.3M Sell
895,494
-665,866
-43% -$12.2M 0.03% 456
2014
Q4 		$20.1M Buy
1,561,360
+406,821
+35% +$5.09M 0.02% 477
2014
Q3 		$14.2M Buy
1,154,539
+1,062,109
+1,149% +$12.3M 0.02% 642
2014
Q2 		$1.46M Sell
92,430
-12,570
-12% -$179K ﹤0.01% 1571
2014
Q1 		$1.59M Buy
+105,000
New +$1.19M ﹤0.01% 1437

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of Montreal's HZNP Position: Q4 2023 in Review

Bank of Montreal sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 153,685 shares — an estimated $17.7M sold.

Bank of Montreal first reported a position in HZNP in Q1 2014 and held it in 39 quarters. The position peaked at $145M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Bank of Montreal reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Bank of Montreal sold 153,685 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $17.7M.
  • Bank of Montreal first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 39 quarters.
  • Bank of Montreal's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $145M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Bank of Montreal's 13F filing for Q4 2023, filed 8 Feb 2024.